Authors

• Thubeena Manickavasagar
• D.J. Hughes (ORCID: https://orcid.org/0000-0003-2641-7632)
• Levente K. Meszaros (ORCID: https://orcid.org/0000-0002-4698-0943)
• Scott Edmonds
• Gary Cook (ORCID: https://orcid.org/0000-0002-8732-8134)
• Damion Bailey
• Spyridon Gennatas (ORCID: https://orcid.org/0000-0002-5635-7696)
• Eleni Karapanagiotou
• James Spicer (ORCID: https://orcid.org/0000-0003-3732-8491)
• Gitasha Chand
• Debra H. Josephs (ORCID: https://orcid.org/0000-0002-5610-9123)
• Hong Hoi Ting
• Vicky Goh (ORCID: https://orcid.org/0000-0002-2321-8091)
• Alexandros Georgiou (ORCID: https://orcid.org/0000-0001-7500-9251)
• Ronan Tegala
• Jessica Johnson (ORCID: https://orcid.org/0000-0002-4519-3120)
• Emma McLean
• Susan Ndagire
• Amelia E.B. Moore
• Sharmistha Ghosh
• Kathryn Adamson

Institutions

• St Thomas' Hospital (GB)
• University of Hertfordshire (GB)
• King's College London (GB)
• Guy's and St Thomas' NHS Foundation Trust (GB)

Publication Details

Journal

British Journal of Cancer

Published

2025-04-05

DOI

https://doi.org/10.1038/s41416-025-02991-w

Citations

2

Primary Topic

Cancer Immunotherapy and Biomarkers

Type

article

Field-Weighted Citation Impact

2.09

Funders

• Wellcome
• Cancer Research UK
• King's Health Partners